Your browser doesn't support javascript.
loading
Pharmacokinetics and pharmacodynamics of TBR-652, a novel CCR5 antagonist, in HIV-1-infected, antiretroviral treatment-experienced, CCR5 antagonist-naïve patients.
Marier, Jean-Francois; Trinh, MyMy; Pheng, Leng Hong; Palleja, Sandra M; Martin, David E.
Affiliation
  • Marier JF; Pharsight, a Certara Company, Montreal, Quebec, Canada.
Antimicrob Agents Chemother ; 55(6): 2768-74, 2011 Jun.
Article in En | MEDLINE | ID: mdl-21486960
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Azepines / Acquired Immunodeficiency Syndrome / HIV-1 / Anti-HIV Agents / CCR5 Receptor Antagonists / Imidazoles Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Azepines / Acquired Immunodeficiency Syndrome / HIV-1 / Anti-HIV Agents / CCR5 Receptor Antagonists / Imidazoles Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2011 Type: Article Affiliation country: Canada